Overview of Flogel

Property	Description
Active ingredient	Carmellose (Carboxymethylcellulose Sodium)
Form	Ophthalmic solution / Eye drops
Pharmacological class	Ophthalmic Lubricant, Tear Substitute
Common use	Temporary relief of eye dryness symptoms
Origin	Semi-synthetic cellulose derivative

What Type of Medicine is Flogel?

Flogel is fundamentally an ophthalmic solution classified as an Ophthalmic Lubricant, placing it within the pharmacological group of Tear Substitutes or artificial tears. This liquid preparation is strictly intended for topical ocular administration and is designed to address functional deficiencies in the eye’s natural tear film. The medicine’s role is primarily mechanical, aiming to improve the physical conditions of the eye's surface rather than exerting a systemic biological effect. This preparation category is utilized to physically improve tear film stability and surface lubrication. The conclusion drawn from this usage is that the medicine helps the eyes stay moist and protected when natural tears are insufficient.

The Composition of Flogel: Carmellose and its Origin

The principal component is the active ingredient Carmellose, which is the International Nonproprietary Name (INN) for Carboxymethylcellulose Sodium. This substance is identified as a semi-synthetic cellulose derivative and is regarded as an inert agent because its function is mechanical, not pharmacological. Flogel is often noted for its specific formulation as a high-viscosity drop, a characteristic that allows for enhanced coating properties on the cornea. Carmellose is dissolved within a sterile aqueous vehicle to create the preparation. This constituent is recognized for its ability to increase viscosity, which helps the solution remain on the eye for a longer duration. Carboxymethylcellulose formulations help augment the natural tear film's capacity to maintain a smooth, protective layer over the corneal epithelium. For patients, this means the formula is effective at creating a lasting protective shield against irritation.

What is the General Purpose of Ophthalmic Lubricants?

The general therapeutic purpose of Flogel is to provide temporary relief from the uncomfortable symptoms associated with eye dryness, such as burning, irritation, and foreign body sensation. The preparation achieves this by forming a stable, protective layer that physically coats the eye’s surface. By ensuring proper lubrication, it reduces friction during blinking, restoring stability to the tear film and mitigating discomfort caused by a lack of moisture. This makes Flogel an appropriate choice for individuals experiencing routine, environmentally induced dryness.

What side effects are possible with Flogel?

Possible side effects and safety information

Flogel, which contains Carmellose Sodium (Carboxymethylcellulose Sodium), is an ophthalmic lubricant whose officially documented safety profile is characterized primarily by local ocular adverse reactions. These effects are consistent with the medicine's topical application and mechanical action as a tear substitute, and systemic adverse reactions are not commonly listed due to negligible systemic exposure.

Regulatory authorities classify side effects by their frequency based on clinical data and post-marketing experience. Most documented reactions fall under Eye Disorders in the System-Organ-Class (SOC) system.

Frequency-Classified Adverse Reactions

The following are examples of adverse reactions listed in official regulatory documents:

Classification	Examples of Adverse Reactions (Ocular)
Common	Eye irritation, burning, discomfort, eye pain, eye pruritus, visual disturbance
Uncommon	Hypersensitivity, blurred vision, increased lacrimation (tearing), eye discharge, foreign body sensation, ocular hyperemia (redness)

Serious Safety Considerations

The primary serious risk documented is hypersensitivity to the formulation’s components, which, though classified as uncommon, may include signs like eye swelling or eyelid edema. Very rare cases of anaphylaxis have been noted in post-marketing reports. The established contraindication for this product is a known allergy to Carmellose Sodium or any of its excipients.

Population and Duration Notes

Due to the negligible systemic exposure of the active ingredient, no special precautions are generally deemed necessary regarding use during pregnancy or lactation. Additionally, official labeling specifies that certain visual side effects, such as blurring of vision, are transient (temporary). If irritation, pain, or changes in vision occur or worsen, regulatory documents note that treatment discontinuation should be considered.

Overdose and Emergency Response

Overdose and When to Seek Help

The official regulatory profile for Carboxymethylcellulose Sodium Ophthalmic Solution (Flogel) is characterized by the product's negligible systemic absorption and non-pharmacological, mechanical action as an ophthalmic lubricant. Consequently, an overdose is officially classified as unlikely to present a hazard or cause severe systemic harm.

Documented Overdose Status

Domain	Official Regulatory Statement
Documented Manifestations	No specific systemic clinical signs or symptoms are documented in official overdose sections.
Severe Outcomes	Officially documented as unlikely to present a hazard following accidental overdose or ingestion, due to the substance's inert nature.
Antidote Availability	No specific antidote is known or required.
Supportive Management	Symptomatic and supportive therapy is the officially recommended approach for cases of accidental ingestion.

Emergency Action Required

Official labeling mandates a clear step for managing accidental oral exposure, as the primary concern is ingestion rather than expected toxicity. If the ophthalmic solution is accidentally swallowed, you must Contact a Poison Control Center or get medical help right away. This regulatory instruction dictates that urgent medical attention must be sought for the action of accidental ingestion, rather than in response to specific severe symptoms.

Therapeutic Uses of Flogel

What Flogel Treats: Main Uses and Benefits

Flogel, containing the lubricant Carmellose (Carboxymethylcellulose Sodium), is applied in clinical settings that involve acute or unstable symptom patterns. The preparation is used as a tear substitute to manage dry eye discomfort. It is relevant in contexts where supportive symptom management is appropriate due to heightened discomfort.

Therapeutic Role and Symptom Clusters

Flogel is commonly applied across conditions characterized by periods of heightened symptoms of ocular discomfort, including the cluster of burning, stinging, and itchiness associated with Dry Eye Syndrome and related ocular surface irritations. It is used in areas where short-term symptom management is appropriate and helps address symptom clusters that may become intense or disruptive to the patient’s comfort.

The preparation is relevant for managing symptoms of frictional discomfort and the sensation of grittiness or a foreign body in the eye. It is applied in scenarios where additional management of discomfort is required, such as in conditions presenting with disruptive symptom manifestations like dry eye disease, ocular surface irritation, or dryness related to environmental exposure.

“The preparation provides support that helps ease the overall symptom burden of conditions marked by increased physiological stress.”

Benefits in Real-World Scenarios

The medicine is relevant in contexts involving heightened systemic burden, such as dryness exacerbated by environmental stress (wind, dry air) or visual strain from prolonged reading or screen use. It is often used when symptoms intensify and supportive relief is needed, contributing to improved comfort during periods of heightened symptoms and supports the patient during difficult episodes by easing distress. The use of this preparation is used to assist with maintaining functional stability when symptoms interfere with routine activities.

Quick Fact: Relief for Persistent Dryness
This preparation is commonly used to help with moderate to persistent dryness in conditions where symptoms may intensify temporarily.

Eligibility and Restrictions for Use

The official regulatory profile for Flogel (Carmellose Sodium ophthalmic solution) is primarily governed by the medicine's topical nature and lack of systemic absorption.

Eligibility Scope

Category	Regulatory Status
Populations for whom use is allowed	Adults and the General Population.
Populations for whom use is contraindicated	Individuals with known hypersensitivity (allergy) to carmellose sodium or to any of the product's excipients.
Pregnancy and lactation eligibility status	Use is permitted during both pregnancy and breastfeeding due to the medicine's negligible systemic exposure and lack of systemic pharmacological activity.
Age-related eligibility rules	Adults are approved. For the pediatric population (children and adolescents), regulatory classifications vary: some sources cite safety and efficacy as established by clinical experience, while others explicitly state that use is not established and no data are available.
Condition-specific eligibility rules	No restrictions are documented for patients with renal or hepatic impairment due to the lack of systemic absorption.
Eligibility-related restrictions	Contact lens wearers must remove their lenses before application and wait a minimum of 15 minutes before re-insertion for products containing preservatives. The medicine must not be used if the solution has changed color or become cloudy.

This structure reflects how official regulatory documents define who can and cannot use the medicine, based on absolute contraindications and conditional restrictions related to administration technique.

What should I know about interactions with other medicines?

Flogel Interactions with other medicines and products

Official regulatory documentation establishes that the interaction profile for Flogel is defined by the medicine’s local, mechanical action and negligible systemic absorption. This characteristic leads to a minimal risk of systemic interactions.

Property	Official Regulatory Documentation
Medicinal product categories with documented interactions:	Other topically administered ocular medications (eye drops and ophthalmic ointments).
Timing-based interaction rules:	Must be separated by an interval of at least 15 minutes between applications.
Systemic Interaction Status:	None documented with systemic medicines, food, alcohol, or supplements.

Resulting Interaction Structure

Official labeling confirms the overall absence of systemic metabolic, transporter, or exposure-altering interactions. Regulatory documents explicitly state that no drug–drug interactions are known or anticipated because the active ingredient does not achieve clinically relevant plasma concentrations. Therefore, the entire interaction profile is structured around one single, local, administration-timing constraint. This constraint is in place because co-administration with other ophthalmic medicines may result in the physical displacement or dilution of the subsequently administered treatment. This risk necessitates the mandatory time separation to preserve the integrity of both treatments administered to the eye surface.

Mechanism of Action

How Flogel works: Mechanism of Action

Flogel primarily functions as an inhibitor of the Cyclooxygenase (COX) enzymes, specifically targeting both COX-1 and COX-2. These enzymes catalyze the conversion of arachidonic acid into prostaglandins, which are key local mediators. By blocking this conversion, Flogel prevents the formation of these chemical signals, initiating its key mechanistic cascade.

The mechanism also involves modulating local cellular activity. Flogel interacts with cell membranes to stabilize them, which limits the release of other local mediators. This action influences the peripheral vascular system, contributing to modifications in localized blood vessel permeability. The final combined effect of reduced prostaglandin levels and stabilized local responses results in decreased nociceptor activation and limited extravasation of fluid (edema), modifying the transmission of afferent signals at the application site.

Dosage and Administration Information

Application Process

Flogel is typically administered as an ophthalmic lubricant to provide relief from dryness and irritation. The application process involves placing the drops directly into the affected eye or eyes. It is common practice to wash hands thoroughly before application to maintain hygiene.

General Steps for Use

Preparation: Ensure the tip of the container does not touch any surface, including the eye or skin, to prevent contamination.
Positioning: Tilt the head back slightly and pull the lower eyelid down to create a small pocket.
Administration: Hold the dropper above the eye and release the prescribed number of drops into the pocket created by the lower lid.
After Application: Close the eye gently for a brief period to allow the solution to spread evenly across the ocular surface.

Usage with Contact Lenses

Individuals who wear contact lenses should consider the specific requirements of their formulation. Some versions of ophthalmic lubricants are compatible with contact lenses, while others may require the removal of lenses prior to application, with a waiting period before reinsertion.

Frequency and Duration

The frequency of application is generally determined by the level of discomfort or the specific needs of the individual. The solution is often used as needed throughout the day to maintain moisture on the surface of the eye. If multiple types of eye drops are being used, a period of time is typically observed between the application of different products to ensure proper absorption.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Flogel

Evidence for Use in Dry Eye Disease Symptoms

Carmellose has been the subject of research exploring short-term symptom changes in populations with mild to moderate dry eye disease. Studies typically involve short-term randomized controlled trials (RCTs) where participants are observed for a few weeks or months. These trials were used in research exploring how symptoms change over time, comparing Carmellose formulations against a placebo or other lubricants.

The research explored outcomes related to physical discomfort and objective functional measures, including Tear Break-Up Time (TBUT) to measure how long the product remained on the eye, and assessments of the surface of the eye. Findings describe patterns observed in the studies related to how patient-reported outcomes evolved during the study period. When comparing Carmellose to other similar tear substitutes, research highlights changes measured, but data often show patterns related to parity in outcomes, and findings were mixed regarding differences across all measurements.

Evidence for Use in Post-Surgical Ocular Protection

Carmellose was also evaluated in research contexts involving fluctuating or unstable symptoms that can occur following certain eye surgeries, such as cataract extraction (phacoemulsification). Studies conducted during periods of increased symptom activity have explored Carmellose as an adjunct—meaning it was used alongside standard post-operative care.

Research examined outcomes related to changes in physical discomfort and physiological factors during the immediate recovery period. Findings help contextualize how patients reported their experience of discomfort. For example, studies reported how symptoms evolved in the observed populations during the first month after the procedure.

Long-Term Research and Follow-up Durations

The available evidence primarily stems from studies observing responses over defined time intervals, meaning follow-up durations were limited. Research examining short-term symptom changes, typically lasting 2 to 4 weeks or up to 3 months, is more common. Long-term outcomes of Carmellose, and lubricant products generally, over many months or years are not fully established by large-scale clinical trials.

What Research Gaps and Uncertainties Remain

While Carmellose has been extensively studied, a common research limitation is that many trials have modest sample sizes or are focused on a narrow population, which means the results apply only to the populations studied. The evidence quality varies across studies, and sometimes the findings were mixed, particularly when comparing Carmellose against the newest generation of active lubricant ingredients. Furthermore, comparative evidence is lacking in some areas, making it difficult to precisely gauge the product’s performance relative to every other available treatment option.

Key Studies & References

Evaluation of Two Artificial Tears Containing Hyaluronic Acid for Post Cataract Surgery Dry Eye Disease: A Randomized Controlled Trial

Frequently Asked Questions (FAQ)

Common questions about Flogel (FAQ)

Q: How long does the effect of Flogel typically last?

According to official product descriptions, Flogel is a high-viscosity solution. This means the medicine is formulated to remain on the eye surface for a longer period than thinner, less viscous tear substitutes. This formulation is intended to provide a prolonged lubricating effect.

Q: Can Flogel be used for general pain relief?

Regulatory documents state that the medicine is indicated solely for the temporary relief of symptoms caused by eye dryness. It is intended only for topical ocular use and is not used for general pain relief in other areas of the body.

Q: What's the difference between Flogel and a regular anti-inflammatory cream?

Flogel is classified as an ophthalmic solution, meaning it is an eye drop intended for use inside the eye. This is distinctly different from a regular anti-inflammatory cream, which is designed for topical use on the skin. The administration route and intended site of action are not the same.

Q: Can Flogel cause a skin rash or irritation?

While irritation and discomfort in the eye itself are commonly reported side effects, regulatory documents mention hypersensitivity as an uncommon risk. Hypersensitivity can present with signs like swelling of the eye or eyelid edema, which involves the area surrounding the eye.

Q: Is Flogel suitable for someone who has allergies?

Official guidance states that a known allergy or hypersensitivity to the active ingredient, Carmellose Sodium, or any of its excipients is a contraindication for use. Regulatory documentation does not specify special restrictions based on having other, unrelated allergies.

Q: Is Flogel used for acute issues or long-term conditions?

Flogel is indicated for the temporary relief of symptoms related to eye dryness. Research supporting its use has typically involved observation periods over defined, limited time intervals. Long-term outcomes over many months or years are not as fully established by large-scale clinical trials.

Q: Is Flogel considered a nonsteroidal anti-inflammatory drug (NSAID)?

Flogel is officially classified as an Ophthalmic Lubricant, which is a type of Tear Substitute. While its mechanism is described in some contexts as involving the inhibition of COX enzymes, its core function is mechanical: to lubricate and protect the eye surface.

Q: Is Flogel a prescription drug or can you buy it over the counter?

Official classifications for medicines in this category describe them as commonly available for purchase without a prescription. These types of lubricating solutions are typically offered over the counter (OTC).

Q: How quickly does Flogel usually start working after use?

Since Flogel functions mechanically as a lubricant, the desired effect of coating and moisturizing the eye surface is expected to occur immediately upon application.

Q: Can I apply Flogel to broken or open skin?

Official documentation specifies that this medicine is strictly an ophthalmic solution intended for instillation into the eye. Its scope of use is limited to ocular application, and it is not intended for application to other surfaces of the body, such as broken or open skin.

Q: What happens if I accidentally use too much Flogel?

Regulatory documents indicate that since the medicine has negligible systemic absorption, no systemic toxicity from accidentally applying more than the recommended amount is expected. The main potential concern is experiencing a temporary (transient) blurring of vision.

Q: Is Flogel habit-forming or addictive?

Official regulatory documentation confirms that Flogel has been assessed and is not known to carry any potential for abuse, dependence, or habit formation.

Q: What does Flogel look like (color, consistency)?

Official product descriptions characterize Flogel as a clear, colorless, or nearly colorless liquid solution. It is often noted for its specific high viscosity, which helps the drop coat the surface of the eye.

Q: Why do some people say Flogel has a strong smell?

Official regulatory documents list all components of the formulation, including excipients like preservatives. It is these excipients that contribute to the product's characteristics, and some individuals may notice a scent based on these non-active ingredients.

Q: Have there been any major recalls or safety warnings for Flogel recently?

Information about the product's status, including any major drug recalls or official safety warnings, is managed and published by government regulatory bodies like the FDA. This information is publicly available through their respective databases.

Q: Where can I find the official prescribing information for Flogel?

Official information, including the full prescribing or product information, is available through government-run sources. Examples of such resources include the FDA’s DailyMed database and the NIH’s MedlinePlus drug information website.

Q: Is Flogel approved by the FDA?

The product's market status, including whether it is approved or recognized as Generally Recognized as Safe and Effective (GRASE) by the FDA, is maintained and listed in official government-run drug databases.

Q: Can I use Flogel if I have a metal implant near the application site?

Regulatory documentation confirms that this medicine has negligible systemic absorption, meaning it does not reach clinically significant levels in the bloodstream. Because of this, it is not anticipated to affect a metal implant in another part of the body.

Q: Why is Flogel not recommended for people with asthma?

Regulatory documentation does not list asthma as a contraindication or special precaution for the use of this medicine. Contraindications are specific conditions that officially forbid the use of the drug.

Q: Can Flogel make me dizzy or drowsy?

Due to the medicine's negligible systemic exposure, systemic side effects are not commonly documented. Official adverse reaction lists for this product do not typically include dizziness or drowsiness as common effects.

Q: Does Flogel make your skin more sensitive to the sun?

Because the medicine is applied only to the eye surface and has negligible systemic absorption, official regulatory documents do not list sun sensitivity (photosensitivity) as a documented side effect or precaution.

Q: Why is the application amount measured in centimeters?

Official dosing instructions for this ophthalmic solution describe the amount to be used in drops to be instilled into the eye. It is not intended to be measured out in centimeters, which is a method sometimes used for topical skin preparations.

Q: Can Flogel be used on the face?

Official product information specifies that this product is strictly for ophthalmic use, meaning it is intended to be instilled into the eye only. The medicine is not intended for administration or use on other parts of the face.

Q: What are the main risks of using Flogel for too long?

Official labeling notes that if eye pain, irritation, or changes in vision occur or worsen, treatment discontinuation may need to be considered. Available research has focused primarily on short-term use, and long-term outcomes are not fully established by large-scale clinical trials.

Q: Why do official documents advise caution with alcohol consumption while using Flogel?

Official regulatory documentation explicitly states that no drug-drug interactions are known or anticipated with systemic medicines, food, supplements, or alcohol. This is because the medicine has a local application and negligible absorption into the bloodstream.

How should Flogel be stored and disposed of?

The safe storage and disposal of Flogel (Carboxymethylcellulose Sodium ophthalmic solution) must adhere to official regulatory conditions to maintain product sterility.

Official Storage Conditions

Requirement	Description
Temperature	Store at room temperature, typically between 15 C and 30 C (59 F and 86 F).
In-Use Stability	Discard immediately after a single use for unit-dose containers. For multi-dose bottles, discard any remaining solution, often within one month of first opening.
Protection Rules	Keep the cap tightly closed after use, and to prevent contamination, the container tip must not touch any surface. The solution must not be used if it changes color or becomes cloudy.

Handling and Disposal

The medicine must be kept out of the reach of children. Unused or expired eye drops must not be thrown away into wastewater or household waste; instead, users should ask a pharmacist for proper disposal instructions.

Flogel